Neopharm Group

About Neopharm Group

Neopharm Group is engaged in research and development, manufacturing, marketing, sales, and distribution of a broad range of products in the health care field in 60 countries globally. Founded in 1941, Neopharm Group has over 900 employees worldwide with offices in Israel, Europe, the U.S., and the Middle East, and annual revenues exceeding $US400 million. The group operates in three main areas: pharmaceuticals, consumer products, and medical devices. Group companies include Neopharm Israel, which provides innovative solutions for improving health in the fields of oncology, hematology, autoimmune and metabolic diseases, neurology, gastroenterology, and dermatology. It also imports unregistered drugs into Israel with a permit from the Ministry of Health and provides medical care to patients at home as an alternative to hospitalization. Neovi, a Swiss-based global biopharmaceutical company, develops and brings to market novel antibody therapies in transplantation medicine, oncology, and immune disorders. Eldan provides medical, analytical, and scientific instruments and equipment, as well as advanced materials and technologies in the areas of healthcare and life science. Neopharm Consumer Products offers wellness and healthcare products through in-house development and partnerships with leading global Consumer Healthcare companies, operating in the areas of nutrition, wet wipes, diapers, skin care, and over-the-counter medicines. Promedico provides logistics and supply chain management services. Neopharm Cure specializes in the preparation and delivery of medicinal treatments given by infusion, customized for patients in hospitals, the community, or at home. DPL specializes in the production, marketing, and export of advanced absorbent products such as disposable diapers, wipes, and sanitary napkins. Working at Neopharm means being part of a large group that operates with humanity, professionalism, and innovation.